Hysteroscopic pictures following danazol therapy in endometrial hyperplasia.

Mauro Busacca, Stefania Luchini, Molinari Ma, A Tonta, G. Marelli
In: Acta Europaea fertilitatis · 1988 · vol. 18(3) , pp. 197–201 · PMID:3439406 · W2418976312
article OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-11 ⓘ

Danazol therapy at 200 mg/day effectively treated endometrial hyperplasia in ten women, as evidenced by histological and hysteroscopic changes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Danazol is a synthetic steroid derived from ethisterone. Ten women with menometrorrhagia have been treated in order to demonstrate the modifications induced by Danazol on hyperplastic endometrium. Histological and hysteroscopic control demonstrated that Danazol Therapy, at a dose of 200 mg/die, is an efficacious treatment for endometrial hyperplasia.

My notes (saved in your browser only)

Condition tags

die_deep_infiltrating

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK